Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions
- PMID: 19376318
- DOI: 10.1016/j.ahj.2008.12.020
Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions
Abstract
Background: In the recently published universal definition of myocardial infarction (MI), a troponin elevation above 3x above the 99th percentile of normal after percutaneous coronary intervention (PCI) is a procedure-related (type 4a) MI. Although troponin rise is common after saphenous vein graft (SVG) PCI, its prognostic value remains undetermined. We aimed to investigate the prognostic value of the universal definition of PCI-related MI in SVG interventions.
Methods: A cohort of 589 unselected consecutives patients with normal preprocedural troponin Ic undergoing isolated SVG PCI with drug-eluting stent implantation was included. Patients were divided into 2 groups according to the peak troponin value post PCI: those with MI defined as a peak troponin value above 3x the 99th percentile of normal post-PCI (MI group, n = 166) and those without (no MI group, n = 423). The primary end point was the rate of major adverse cardiac events including death, MI, and target vessel revascularization at 1-year follow-up.
Results: Baseline characteristics were similar between the 2 groups. In the MI group, patients had more complex angiographic features (type C lesions: 44.7 vs 34.8%; P = .006). The rate of direct stenting and distal protection use were similar in the 2 groups (MI vs no MI: 29.2 vs 28.7%; P = .9 and 32 vs 37.5%; P = .24, respectively). Patients in the MI group had a worse inhospital course but a similar 1-year rate of major adverse cardiac events (22.3 vs 19.1%; P = .39).
Conclusion: Procedure-related MI after PCI, as defined by the universal definition, is associated with an adverse inhospital course but may not predict long-term outcome in SVG PCI.
Comment in
-
Myocardial infarction in saphenous percutaneous intervention: are we really doing our best?Am Heart J. 2009 Sep;158(3):e39; author reply e41. doi: 10.1016/j.ahj.2009.06.016. Epub 2009 Jul 22. Am Heart J. 2009. PMID: 19699850 No abstract available.
Similar articles
-
Outcomes of patients with acute myocardial infarction from a saphenous vein graft culprit undergoing percutaneous coronary intervention.Catheter Cardiovasc Interv. 2011 Jul 1;78(1):23-9. doi: 10.1002/ccd.22873. Epub 2011 Mar 16. Catheter Cardiovasc Interv. 2011. PMID: 21061247
-
Drug-eluting stenting of saphenous vein graft versus native coronary artery supplying the same myocardial perfusion territory: a pilot retrospective 3-year follow-up.J Invasive Cardiol. 2012 Oct;24(10):516-20. J Invasive Cardiol. 2012. PMID: 23043035
-
Thrombus predicts ischemic complications during percutaneous coronary intervention in saphenous vein grafts: results from TARGET (do Tirofiban and ReoPro give similar efficacy trial?).Catheter Cardiovasc Interv. 2007 Apr 1;69(5):623-9. doi: 10.1002/ccd.20963. Catheter Cardiovasc Interv. 2007. PMID: 17192960 Clinical Trial.
-
Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition.QJM. 2009 Jun;102(6):369-78. doi: 10.1093/qjmed/hcp005. Epub 2009 Mar 13. QJM. 2009. PMID: 19286891 Review.
-
The prognosis of periprocedural myocardial infarction after percutaneous coronary interventions.Cardiovasc Revasc Med. 2013 Jan-Feb;14(1):32-6. doi: 10.1016/j.carrev.2012.10.006. Epub 2012 Nov 17. Cardiovasc Revasc Med. 2013. PMID: 23164601 Review.
Cited by
-
Surgical myocardial revascularization of patients with ischemic cardiomyopathy and severe left ventricular disfunction.Clinics (Sao Paulo). 2010;65(1):3-8. doi: 10.1590/S1807-59322010000100002. Clinics (Sao Paulo). 2010. PMID: 20126339 Free PMC article.
-
Effect of Evolocumab on Type and Size of Subsequent Myocardial Infarction: A Prespecified Analysis of the FOURIER Randomized Clinical Trial.JAMA Cardiol. 2020 Jul 1;5(7):787-793. doi: 10.1001/jamacardio.2020.0764. JAMA Cardiol. 2020. PMID: 32347885 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous